Intriguingly, in contrast to the initial tumour development stages where ARID1A was shown to support tumorigenesis, the authors also demonstrated that both heterozygous and homozygous ARID1A deletions accelerated HCC progression and metastasis following initial tumour establishment. The gene discussed is ARID1A; the disease is hepatocellular carcinoma.